Dorsey Wright & Associates’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-940
Closed -$57K 371
2021
Q2
$57K Hold
940
0.01% 171
2021
Q1
$31.7K Buy
940
+540
+135% +$18.5K 0.37% 144
2020
Q4
$12K Buy
+400
New +$9.63K ﹤0.01% 293

Other funds holding LDL

Dorsey Wright & Associates's LDL Position: Q3 2021 in Review

Dorsey Wright & Associates sold out of Lydall, Inc. (LDL) in Q3 2021, closing a stake of 940 shares — an estimated $57K sold.

Dorsey Wright & Associates first reported a position in LDL in Q4 2020 and held it in 3 quarters. The position peaked at $57K in Q2 2021. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.

  • Dorsey Wright & Associates reported no remaining Lydall, Inc. position as of Q3 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 940 Lydall, Inc. shares in Q3 2021, an estimated $57K.
  • Dorsey Wright & Associates first reported a position in Lydall, Inc. in Q4 2020 and held it in 3 quarters.
  • Dorsey Wright & Associates's Lydall, Inc. position peaked at $57K in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.

Based on Dorsey Wright & Associates's 13F filing for Q3 2021, filed 26 Oct 2021.